Barcelona, Spain

Prous Santiago Rull



 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Prous Santiago Rull: Innovator in Hepatitis Treatment

Introduction

Prous Santiago Rull is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. His innovative work has led to the development of a unique method for preparing amorphous silibinin, which has potential applications in treating viral hepatitis.

Latest Patents

Prous Santiago Rull holds a patent for "Amorphous silibinin for the treatment of viral hepatitis." This invention relates to a method for the preparation of amorphous silibinin derived from a milk thistle fruit extract. The method enhances the release rate and improves the absorbability or bioavailability of silibinin. The amorphous silibinin is particularly useful for treating or preventing liver diseases, especially viral hepatitis, in patients who are undergoing or have undergone liver transplantation. The formulation is designed for oral administration, making it a practical option for patients.

Career Highlights

Throughout his career, Prous Santiago Rull has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Euromed S.a. and Madaus GmbH. His experience in these organizations has contributed to his expertise in developing innovative treatments for liver diseases.

Collaborations

Prous Santiago Rull has collaborated with several professionals in his field. Among his notable coworkers are Lucio C Rovati and Astrid Nagell. Their collective efforts have further advanced the research and development of effective treatments for liver conditions.

Conclusion

Prous Santiago Rull is a distinguished inventor whose work in the field of hepatitis treatment has the potential to improve patient outcomes significantly. His innovative approach to amorphous silibinin exemplifies the importance of research and development in addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…